Andere talen 4basebio PLC

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:18 05-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.565 ^GBX	+0,97%		+1,62%	+130,15%

28/06	4Basebio plc kondigt aan dat Hansjorg Plaggemars, niet-uitvoerend bestuurder, terugtreedt uit de raad van bestuur	CI
05/06	4basebio PLC rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

4basebio Plc - Result of AGM	28/06
4Basebio plc Announces Hansjörg Plaggemars, Non-Executive Director, Step Down from the Board	28/06
4basebio Plc - Holding(s) in Company	11/06
4basebio Plc - Holding(s) in Company	11/06
4basebio Plc - Holding(s) in Company	11/06
4basebio Plc - Holding(s) in Company	11/06
4basebio : Results Announcement 2023	05/06
4basebio : Form of Proxy 2024	05/06
4basebio : Notice of AGM 2024	05/06
4basebio Plc - Final Results and Notice of AGM	05/06
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2023	05/06
4basebio Plc - Holding(s) in Company	30/05
4basebio to supply synthetic DNA for mRNA vaccine program	10/04
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	10/04
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	10/04
4basebio updates markets on "key milestone" with client	21/03
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	21/03
Alpha Real Trust says in "robust" financial shape	01/03
4basebio wins DNA supply contract to support RNA therapies	01/03
4basebio Wins Synthetic DNA Supply Tender from CPI	01/03

Geen resultaten voor deze zoekopdracht